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Background: Diagnostic definitions for depressive disorders remain a debated topic, despite 
their central role in clinical practice and research. We use both recent evidence and nationally 
representative data to derive an empirically-based modification of DSM-IV/-5 Major Depressive 
Disorder (MDD). 
Method: A modified MDD diagnosis was derived by analyzing data from Collaborative 
Psychiatric Epidemiology Surveys, a multistage probability sample of adults (n = 20 013; age ≥ 18 
years) in coterminous USA, Alaska and Hawaii. The old and the newly suggested MDD definitions 
were compared for their associated disability (WHO Disability Assessment Schedule and number 
of disability days in past month), suicide attempt, and other covariates. 
Results: Our data-driven definition for major depression was "lack of interest to all or most 
things" plus four other symptoms from the set {weight gain, weight loss, insomnia, psychomotor 
retardation, fatigue, feelings of worthlessness, diminished ability to think/concentrate, suicidal 
ideation/attempt}. The new definition captured all the disability implied by MDD and excluded 
cases that showed no greater disability than the general population nor increased risk of suicide 
attempts. The lifetime prevalence of the new diagnosis was 14.7% (95% CI = 14‒15.4%) of the 
population, slightly less than for the old definition (16.4%; CI = 15.4‒17.3%). 
Limitations: Only conservative modifications of MDD could be studied, because of restrictions in 
the symptom data. 
Conclusions: With only small adjusting, the new definition for major depression may be more 











Clinical definitions for depressive disorders remain a debated topic, despite the high prevalence 
and burden of disability of these disorders. Recent studies have investigated the depressive 
disorders at the level of individual symptoms instead of composite clinical definition of Major 
Depressive Disorder (MDD)1 (Bringmann et al., 2015; Cramer et al., 2012; Fried and Nesse, 2015; 
Keller et al., 2007; Keller and Nesse, 2005; Lux and Kendler, 2010; Oquendo et al., 2004). The 
symptom-level analysis is attractive for basic research because the definition of the MDD 
"syndrome" is not well established empirically (Haslam et al., 2012; Keller et al., 2007; Loo et al., 
2012; Lux and Kendler, 2010; Solomon et al., 2001). At the same time, clinical practice requires 
criteria by which to assign individuals to treatment groups, and there is some evidence to 
support a temporal clustering of symptoms which is consistent with sudden phase transitions 
characteristic to syndromatic states (Hosenfeld et al., 2015; van de Leemput et al., 2014). 
Accordingly, there is a challenge to provide empirically based answers to the question "when 
does depression become a mental disorder" (Maj, 2011a, 2011b). Treatment assignment based 
on single symptoms may be infeasible and reliable biomarkers identifying depression are lacking, 
implying that symptom combinations need to be considered in both research and treatment. This 
paper draws from the new symptom-level findings and uses United States national-level 
estimates to derive an empirically-based recommendation for a more clinically salient definition 
                                                        
1 Abbreviations: MDD = DSM-IV Major Depressive Disorder; MD = an alternative definition for 
Major Depression to be derived; CPES = Collaborative Psychiatric Epidemiology Surveys; 
WHODAS = World Health Organization's Disability Assessment Schedule; WMH-CIDI = World 
Mental Health Survey Initiative's version of the Composite International Diagnostic Interview 
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for the Major Depression (MD; we drop the "Disorder" to distinguish between the suggested new 
ideas and the old definition, and to encompass both episodes and disorder). 
The current Major Depressive Disorder (MDD) diagnosis requires the presence of at least 
one of the two core symptoms: (1) depressed mood and/or (2) markedly diminished interest or 
pleasure in all, or almost all, activities (American Psychiatric Association, 2013). However, it can 
be difficult to define depressed mood or sadness without referring to some other symptoms. For 
example, according to DSM-5 depressed mood is indicated "by either subjective report (e.g., feels 
sad, empty, hopeless) or observation made by others (e.g., appears tearful)" (American 
Psychiatric Association, 2013). But, how does one know when one is feeling sad? In April 18th 
2016, Wikipedia defined sadness as "emotional pain associated with, or characterized by feelings 
of disadvantage, loss, despair, helplessness, disappointment and sorrow", which seems many 
things rather than one. In more quantitative terms, we have previously found that, after taking a 
sadness item into account, other self-report items provided little predictive value for the WHO-
CIDI diagnosis of MDD (Rosenström et al., 2015); this is an expected finding when the "sadness" 
item implicitly implies multiple other symptoms. In a prospective network analysis of depressive 
symptoms, Bringman et al. (2015) showed that sadness has a high "indegree" but a low 
"outdegree" and "betweenness" in relation to other symptoms, suggesting that (statistically) it 
mostly summarizes other prevailing symptoms instead of predicting them. Those with a lot of 
problems (symptoms) are likely to become sad (endorse the symptom in future), but the sad who 
currently lack the other problems are relatively unlikely to get lot of problems in the future. 
Among the depressive symptoms, anhedonia (low positive affect) has been found to be 
relatively specific to depression e.g. when comparing depression, anxiety, and schizopherenia, 
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whereas "depressed mood" represents "a mixture of relatively high NA [negative affect] and 
moderately low PA [positive affect]", therefore being less specific to depression and more related 
to general distress (Clark and Watson, 1991; Joiner et al., 2003). Ideally, constructing a data-
driven definition should start from the most elementary (specific) components available rather 
than use variables that already are a priori given compositions of many elements. Furthermore, 
sadness is frequently seen as a normal, adaptive response to loss (Kleinman, 2012; Wakefield and 
First, 2012; Wakefield and Schmitz, 2013). In contrast, lack of interest in "all, or almost all, 
activities" should reliably intervene with goal-directed behaviors. Therefore, anhedonia may also 
be intrinsically more disabling than sadness. 
Based on the findings cited above, we take only "diminished interest in all, or almost all, 
activities" as the core feature of depression in our analysis, as learning models of depression have 
done (Griffiths et al., 2014; Trimmer et al., 2015). For ease of reference, we call this "lack of 
interest" also as "anhedonia", although strictly speaking, it refers to lack of pleasure. We then 
study the following empirical questions: How do the other depressive symptoms distribute in the 
anhedonic population and what would be a sensible definition of depressive disorder based on 
that distribution? How much this new definition of depression overlaps with the old one? Which 
one of the definitions, the old or the new, is more clinically relevant? A diagnostic definition that 
implies higher level of disability, longer episodes, and greater probability of suicide attempts 
than an alternative definition is an example of comparatively "clinically relevant" diagnosis. 
These questions are analyzed here using a representative population sample of psychiatric 
symptoms in the United States, the World Health Organization's (WHO's) Collaborative 




Sample and procedures 
CPES data joins together three multi-stage area probability samples, the National Comorbidity 
Survey Replication (NCS-R), the National Study of American Life (NSAL), and the National Latino 
and Asian American Study of Mental Health (NLAAS). Collection of the samples were funded by 
the National Institute of Mental Health and they were selected using the sampling frames and 
sample selection procedures that are common to the University of Michigan Survey Research 
Center’s National Sample design, and they shared essential scientific objectives and survey 
instrumentation for mental health diagnostics. The joint sample design and sampling methods for 
the CPES data have been previously described (Heeringa et al., 2004) and the data was available 
to us via the Inter-university Consortium for Political and Social Research (ICPSR) service 
(Alegria et al., 2015). The joint sample represents all adults (i.e., age 18 years or more) residing in 
households in coterminous United States, Alaska and Hawaii, excluding institutionalized persons 
and those living on military bases (NCS-R and NSAL also excluded non-English speakers). 
CPES is a "complex sample design" that allows for unbiased estimation of population 
statistics for the United States of America, but this requires survey-weighted estimation 
(Heeringa et al., 2004; Lumley, 2010). The CPES weights are products of a weight for unequal 
probability of selection, a weight for nonresponse, and a weight for post-stratification. The 
unequal probability of selection per selected individual results from a four-stage sampling 
process: a primary stage sampling of U.S. Metropolitan Statistical Areas and counties, followed by 
second-stage sampling of area segments, a third-stage sampling of housing units, and a fourth-
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stage of random selection of eligible respondents from the housing units. The sample is post-
stratified to a 11 × 12 grid of population totals for geographic domain by race/ancestry 
(Vietnamese, Filipino, Chinese, All other Asian, Cuban, Puerto Rican, Mexican, All other Hispanic, 
Afro-Caribbean, African-American, White, All Other). The final CPES sample includes 20 013 
individuals (8550 men and 11 463 women). 
Assessment instruments 
The selected respondents were interviewed according to the World Mental Health Survey 
Initiative's version of the Composite International Diagnostic Interview (WMH-CIDI), which is a 
modified version of the original WHO-CIDI (Kessler and Üstün, 2004). Both WMH-CIDI and the 
other CPES questions were administered using a computer-assisted interview (Alegria et al., 
2015). Although the WMH-CIDI allows for both 12-month and lifetime diagnoses, for simplicity, 
we concentrate on the data on lifetime diagnoses and on the presence versus absence of the 
depressive symptoms. A sensitivity analysis is conducted for a central disability outcome using 
12-month diagnoses obtained by additionally requiring positive endorsement on the CPES 
variable "V00928" (an episode of being sad/or/discouraged/or/uninterested and having other 
problems during the past 12 months). 
The presence of a symptom was determined exactly as in the "DSM-IV Major Depressive 
Episode" part of the ICPSR documentation for diagnostic algorithms (Alegria et al., 2015). For 
example, presence of anhedonia was inferred when the participant had answered positively to 
either one of the two diagnostic questions. The first question was "Think about the period of 
[(several days/two weeks)] or longer during that episode when your 
[(sadness/or/discouragement/or/lack of interest)] and other problems were most severe and 
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frequent. During that period of [(several days/two weeks)], did you lose interest in almost all 
things like work and hobbies and things you like to do for fun?". The second one was "Think 
about the period of [(several days/two weeks)] or longer during that episode when your 
[(sadness/or/discouragement/or/lack of interest)] and other problems were most severe and 
frequent. Did you feel like nothing was fun even when good things were happening?". Also the 
diagnosis of Major Depressive Episode was exactly as described in the diagnostic algorithm, with 
the exception that we did not use the bereavement exclusions in the E section of the document. 
The criterion has been highly controversial (Bolton et al., 2016; Kendler et al., 2008; Mojtabai, 
2011; Shear et al., 2011; Wakefield and First, 2012; Wakefield and Schmitz, 2013; Zisook et al., 
2007), and the focus of this study is on improving the diagnostic symptom combination. 
Nevertheless, it is possible that the removal of sadness from the MD criteria herein renders the 
bereavement exclusion a non-problem. Exclusions for episodes due to physical illness and/or 
lack of clinically significant impairment were in place, but mania and/or psychosis hiearchy 
exclusions were not used. 
Covariates 
In addition to WMH-CIDI, we use the retrieved responses to the questions "Beginning yesterday 
and going back 30 days, how many days out of the past 30 were you totally unable to work or 
carry out your normal activities because of problems with either your physical health, your 
mental health, or your use of alcohol or drugs?" This variable ("V04452" in CPES codebook) is 
called "disability days" herein. In addition to the disability days, we use data on the World Health 
Organization's Disability Assessment Schedule (WHODAS). CPES data includes six variables that 
score disability from 0 (none) to 100 (max. disability) in the WHODAS domains of Cognition (the 
9 
 
variable "V08813"), Mobility ("V08814"), Self care ("V08812"), Social interaction ("V08818"), 
Role functioning or time out of role ("V08815"), and Participation or role impairment ("V08816") 
(Alegria et al., 2015). Herein, the WHODAS variable was the average of these six normalized 
disability indicators. 
Disability days and WHODAS variables are indicators of clinical relevance. Another 
previously used indicator of relevance is persistence of the condition, which reflects temporal 
burden implied by the diagnosis (@ Wakefield and Schmitz, 2013). Very short episodes of a 
disorder may not be clinical relevant because the implied disability is so short-lived (cf. common 
cold) and because potential treatments might not work fast enough to provide benefits during 
the lifespan of the disorder. Therefore, we studied the length of the worst (variables "V00858" 
and "V00859"), the last (most recent; variables "V00861" and "V00862"), and the longest 
("V00948" and "V00949") episode of being "sad/or/discouraged /or/uninterested" while also 
having "some of the other problems most of the day nearly every day". 
As outcomes of depression diagnoses in Logistic regression, we studied the subjects' 
interview reports of having attempted suicide previously (value 1 in the variable "V02044"), 
having a low education (12 or less education years in age 21 or more; constructed from variables 
"V08172" and "V07306", resp.), being not married nor cohabiting (value 1 in "V08759"), feeling 
that one is a burden to others due to health problems (problems interfered with activities of close 
ones a lot or extremely; value 4 or 5 in "V06811"), being unhappy when taking all things together 
(value 4 in "V06870"), and having a depressed relative (value 1 or bigger in "V06929"). All these 
variables are potentially associated with depression based on well-known previous research, and 




CPES project distributes "pseudo" primary sampling unit and strata information (very similarly 
to NHANES III multistage-design) (Lumley, 2010)). Jointly these information are sufficient to 
provide good approximations to sampling errors via Taylor Series Linearization, as applied here 
(Binder, 1983; Lumley, 2010). Specifically, we used the statistical software R version 3.2.2 (2015-
08-14), supplemented with the Survey package version 3.30-3 (Lumley, 2010, 2004). Survey-
design objects were specified by inserting CPES variables "SECLUSTR" and "SESTRAT" to the "id" 
and "strata" arguments of the "svydesign" function, respectively (argument "nest" = TRUE). The 
"CPESWTSH" variable was the input to the "weights" argument, implying that we used all 
available cases in the CPES data; this is in contrast to the weights "CPESWTLG" that would select 
for the subset of NCS-R participants who participated in both Part I and Part II of the NCS-R (note 
that in CPES User Guide this latter variable is named as "CPESWGTS", but such variable cannot be 
found from the codebook or the data). 
All analyses were based on survey-weighted estimates, as computed by the relevant 
methods in the Survey package. Specifically, all means, standard deviations, covariances, and 
correlations are survey-weighted population estimates, and the (varimax-rotated) exploratory 
factor analysis (Lawley and Maxwell, 1971) was based on the survey-weighted product-moment 
covariance matrix and maximum weighted likelihood estimation ("svyfactanal" function in the 
Survey package). Parallel analysis for number of factors to retain was used, (Horn, 1965; 
Humphreys and Montanelli Jr, 1975) as in other recent structural investigations (Fried et al., 
2016; Uher et al., 2008), and implemented using "nFactors" R package, version 2.3.3, and by 
comparing the survey-weighted correlation matrix eigenvalues to mean eigenvalues of the 
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null/reference (no-correlations) distibution. Eigenvalues capture the amount of variation along 
principal components and are typically arranged in a descending order. The parallel-analysis 
reference distribution is generated using uncorrelated items and therefore the eigenvalues 
resulting from it are affected only by sampling error, not any 'underlying' factor. Thus, the real-
data eigenvalues exceeding the reference distribution suggest underlying factors, the number of 
which corresponds to the running number of the last descending-order eigenvalue that still 
exceeds the equivalent reference. Parallel analysis has been found to perform well, and it is often 
chosen because classic (likelihood-ratio) tests for factor number have been found biased 
(Hayashi et al., 2007). 
We use exploratory factor analysis strictly as a method for rough exploration of symptom 
correlations instead of modeling latent constructs; the suggested diagnostic measures were 
viewed as formative tools, as recommended in recent psychometric and philosophically oriented 
psychiatric research (Fried et al., 2016; Kendler, 2015). In a way of sensitivity analysis, or 
robustness analysis, we also provide an oblique bifactor rotation in the supplementary material 
using "GPArotation" R package, version 2014.11-1 (Jennrich and Bentler, 2012). 
The quasi-Poisson regression coefficients are survey-weighted estimates. Poisson 
regression is an appropriate regression method for an outcome variable that is a count (Gelman 
and Hill, 2007), as for the number of disability days, and the quasi-Poisson specification was used 
as per instructions in the Survey package's help page for the "svyglm" function; it is also the 
proper specification for taking into account possible non-Poisson dispersion in the outcome 




A data-driven definition for MD 
Altogether 82% of those who suffer from sadness or anhedonia, suffer from both. Overall, the 
prevalence of the other symptoms is at least as high in the anhedonic as in the sad people 
(Supplementary Table S1). Given these data and the arguments in the Introduction, the decision 
to limit the core symptoms to anhedonia seems reasonable and will be in effect from this point 
onwards. 
While all the symptoms are correlated in the general population, many were virtually 
uncorrelated in the anhedonic population (see Supplementary Table S2). Parallel analysis 
indicated that four factors are needed to summarize the symptom data among the anhedonic 
population (Figure 1). The symptoms that represent two conditions (e.g., having insomnia or 
hypersomnia) are split into two separate symptoms, because there are no a priori reasons to 
believe that they represent similar etiologies (also previous studies have endorsed this choice) 
(Loo et al., 2012). 
We conducted an explanatory factor analysis using survey-weighted covariance matrix 
and four latent dimensions (Table 1). The three first factors appeared to capture the self-
contradictory aspects of the DSM-5 depressive symptoms (e.g., one cannot simultaneously be 
both insomnic and hypersomnic), being clear methods (or 'nuisance') factors as expected. 
However, explicit modeling of these factors may decrease bias in the remaining factors. Indeed, 
the final factor resembled the familiar concept of depressive syndrome: almost all symptoms 
loaded positively on it, except psychomotor agitation and hypersomnia (loading < 0.1). The 
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Supplementary Table S3 verifies that a similar interpretation held for an oblique bi-factor 
rotation. Bi-factor rotation re-interprets the factor model by trying to enforce one general factor 
and several non-overlapping secondary factors. However, hypersomnia and psychomotor 
retardation still had very weak loadings onto the general factor despite this attempt of enforcing 
a general syndrome for all the symptoms. The cut-off value 0.1 for a ‘meaningful’ factor loading, 
which is the default of the base package of R, may appear liberal in conventional psychometric 
terms. However, we are examining correlations conditioned on having anhedonia. Because all the 
traditional depressive symptoms are correlated with each other, the conditioning attenuates the 
correlations and factor loadings. Thus, what conventionally might be seen a liberal cut-off 
actually reflects our choice to be conservative in leaving out traditionally used depressive 
symptoms from the new definition. 
To define MD both faithfully for the data and with minimal changes compared to DSM-5, 
we thus define the present MD construct as anhedonia plus four other symptoms from the set 
{weight gain, weight loss, insomnia, psychomotor retardation, fatigue, feelings of 
worthlessness, diminished ability to think/concentrate, suicidal ideation/attempt}. In 
other words, we leave out sadness as discussed in the Introduction, and psychomotor agitation 
and hypersomnia because, in the anhedonic population, they did not significantly load onto any 
shared factor with most of the other symptoms. We use anhedonia (a core symptom) plus four 
other symptoms (i.e., total of five) as the requirement for diagnosis, in an analogy to DSM-5. As in 
the old definition for MDE, the symptoms needed to be present during the same two-week period 
and the exclusions for episodes due to physical illness and/or lack of clinically significant 
impairment were in place (these requirements had little effect on the associations between 




Prevalence and demographics of MD in the United States 
Having found an alternative syndromal definition for MD, we proceeded to estimate its 
prevalence and associated disability. The lifetime prevalence of MD was 14.7% (95% CI = 
14‒15.4%) of the population, whereas the prevalence of the usual DSM-IV MDD was 16.4% (95% 
CI = 15.4‒17.3%). Despite the similar prevelances, MD does not capture the exact same people as 
MDD, as evident from Table 2. 
The Supplementary Table S4 displays a summary of the sample. Overall, those who would 
get a diagnosis of DSM-IV MDD without getting the (newly suggested) diagnosis of MD are closer 
to the general population in most characteristics than the MD and MDD groups. On average, those 
diagnosed with MDD but no MD have 1.87 symptoms less than those with both (Cohen's d = 1.89, 
t = 35.7, p < 0.001). 
Disability associated with MD versus MDD 
Among the two definitions, DSM-IV MDD and our new MD, the MD is much more strongly 
associated with disability days than MDD (Table 3). In fact, those DSM-IV MDD diagnoses that did 
not simultaneously satisfy the criteria for MD did not have a statistically significant effect on the 
number of disability days (Table 3). Furthermore, those who satisfied MDD criteria without 
satisfying the MD criteria did not significantly differ from the rest of the population in WHODAS 
score (Cohen's d = 0.015, t = 0.323, p = 0.747), whereas those having MD without MDD did differ 
(d = 0.755, t = 6.98,  p < 0.001; Supplementary Table S4). In addition to Table 3, we checked 
analogous results for the group having both MD and MDD, finding that predicted disability is 
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between MDD and MD as expected (coefficient 0.573, CI = 0.323‒0.823). Similarly, we verified 
that the average WHODAS score increased through the sub-groups having MDD without MD, 
MDD, MDD and MD, MD, and MD without MDD (3.297, 4.954, 5.557, 5.979, 8.09, resp.), showing a 
gradient of increasing disability when moving from DSM-5 MDD to the newly suggested MD 
definition. 
Regarding effect sizes, the quasi-Poisson regression coefficient of 0.457 for the DSM-IV 
MDD diagnosis implies a 58% higher number of disability days per month in comparison to those 
not satisfying the MDD criteria. In comparison, the quasi-Poisson regression coefficient of 0.833 
for the MD diagnosis implies a 130% higher number of disability days per month in comparison 
to those not satisfying the MD criteria. In other words, the rate effect of MD on disability days is 
2.24 times that of the DSM-IV MDD (see Supplementary Table S4 for group averages). 
The 12-month diagnoses imply even more disability than the lifetime diagnoses, because 
the disability days outcome refers to the past month (Table 3). The highest increase in disability 
days was associated with the MD diagnosis without MDD. This condition increased the number of 
disability days by 312%. The qualitative pattern of findings was similar to that of the lifetime 
diagnoses (Table 3). The rest of the paper will discuss lifetime diagnoses only. 
Correlates of MD versus MDD 
We now continue the characterization of the MDD sufferers without MD, the MDD sufferers, the 
MD sufferers, and the MD sufferers without MDD, by assessing different types of disability and by 
using other clinically relevant variables than disability. Figure 2 shows how the diagnostic groups 
are represented in the WHODAS sub-scales and episode length, further characterizing the above 
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findings on disability, whereas the Figure 3 shows odds ratios for several other binary outcomes 
and for a few common DSM-IV disorders other than depressive disorders. 
Most notably, MD sufferers are characterized by more impairment in the WHODAS 
domains than in the MDD sufferers, and a higher likelihood of previous suicide attempt. It is 
possible to show by explicit test within a multivariate logistic regression model e.g. that MDD 
without MD implies a decreased risk of suicide (OR = 0.371, p < 0.001), whereas the other forms 
of depression in general imply an increased risk (OR = 2.35, p < 0.001). Of course, this is readily 
evident from the Figure 3. In contrast, "unhappines", feeling that one is a "burden to others", 
familiality, and marriage status did not show marked differences across the diagnostic groups. 
MD sufferers without MDD were distinguished from the other groups by their higher likelihood 
of having low educational status, which may be related to their higher cognitive disability and 
time out of role (e.g. studying). Although we did not find drastic differences in episode length, 
those who had MD without MDD had longer longest depressive episode than those who had MDD 
without MD (d = 0.215, t = 2.43, p = 0.017), and a similar but statistically non-significant trend 
was observed for the worst and the last episodes (d = 0.091, t = 1.74, p = 0.084, and d = 0.244, t = 
1.37, p = 0.173, respectively). 
MD had a higher level of comorbidity with other DSM-IV disorders than MDD, even after 
adjusting for the WHODAS score (Figure 3). Differences in comorbidity were most clear for 
substance use disorders, attention deficit disorder and panic disorder, but not so much for 
anxiety or post-traumatic stress. For example, MDD and MD had clearly non-overlapping 
confidence intervals for the attention deficit disorder (Figure 3); in that case, 7.15% (95% CI = 
5.52‒8.79%) of MDD cases had a lifetime comorbid attention deficit disorder, whereas the same 
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estimate for MD was 11% (95% CI = 8.85‒13.1%). Altogether 52.9% (95% CI = 50.5‒55.4%) of 
the MDD cases had had some of the other diagnoses studied in the Figure 3 during their lifetime, 
whereas 61.2% (95% CI = 58.9‒63.5%) of the MD cases satisfied the criteria for some of the 
other non-depression lifetime diagnoses. 
Discussion 
Here we propose an alternative, data-driven definition for MD that is similar in spirit to the well-
known DSM-IV definition of MDD, but based on less conceptually overlapping symptom 
descriptions. The new MD is slightly less prevalent in the population than the familiar MDD, but 
significantly more associated with disability and suicide attempts than the MDD. In fact, those 
who satisfied MDD criteria without satisfying the MD criteria did not significantly differ from the 
rest of the US population in terms of disability days or WHODAS score. In this sense, the new MD 
definition is more pertinent to the question "when does depression become a disorder" than the 
old MDD definition (Maj, 2011a, 2011b; Wakefield and Schmitz, 2013). 
Although our alternative definition of MD is partly data-driven, it is clear that it stands 
firmly on the shoulders of the old MDD definition. This conservative modification is not 
accidental. While it is important to study the depressive symptoms as dynamic systems 
(Bringmann et al., 2015; Cramer et al., 2012) and search for biomarkers (Kapur et al., 2012), 
neither of the approaches currently promises fast advances. High-dimensional nonlinear system 
are difficult to analyze both theoretically and empirically, and some of the biomarkers for 
depression have turned out to be relevant only for sickness behaviors but not cognitive 
symptoms of depression (Jokela et al., 2015) or suffer from a very low predictive value (Fried and 
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Kievit, 2015). Neurovegetative symptoms associated with sickness behaviors have been found 
less strongly associated with clinically relevant characteristics of depression than cognitive 
symptoms (Lux and Kendler, 2010). Another practical argument for gradual progress is that the 
clinical community has shown resistance to drastic changes in nosology (Kendler, 2013). 
Furthermore, the recently endorsed "coherence theory of truth" in context of psychiatric 
nosology stresses that a new proposal should fit well with other things we know (Kendler, 2015), 
and such a fit is more difficult to demonstrate for definitions that have less to do with the existing 
pool of knowledge. We hope that the present definition of MD is both a conservative modification 
and a change for the better, and serves to keep the scientific method—a process of successive 
revisions—running despite the apparent standstill. 
According to a longitudinal symptom-network analysis, sadness, a central part of the core 
symptom of "depressed mood" in the DSM-IV and DSM-5 definitions of MDD, does not appear to 
play a key role in the emergence of multiple depressive symptoms (Bringmann et al., 2015). 
Moreover, sadness may not directly imply pathology (Kleinman, 2012; Maj, 2011b; Wakefield and 
Schmitz, 2013). Further still, terms that reflect "depressed mood" (e.g., sad or blue) appear less 
specific to depression in comparison to anhedonia (Clark and Watson, 1991; Joiner et al., 2003). 
This study demonstrated that a definition without the sadness-including symptom better 
captures clinically relevant cases of depression. This new definition retained the other core 
symptom, anhedonia, in its original role, which is in line with the models of goal-directed 
behavior that have recently evoked much interest regarding psychiatric applications (Griffiths et 
al., 2014; Maia and Frank, 2011; Trimmer et al., 2015); for example, Griffiths et al. conclude: 
"Anhedonia, a common symptom in depression, maps closely onto deficits within outcome 
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valuation circuitry, and is the clearest example of how problems with reward value lead to 
reductions in goal-directed action" (Griffiths et al., 2014). 
In this paper, we defined both the old and the new depression diagnosis without the 
bereavement exclusion criterion, because it has been very controversial (Bolton et al., 2016; 
Kendler et al., 2008; Kleinman, 2012; Mojtabai, 2011; Shear et al., 2011; Wakefield and Schmitz, 
2013), and because it is not included in the most recent criteria (American Psychiatric 
Association, 2013). Also, the discussion on the bereavement criterion is not central for the 
present paper. We were interested in finding a better symptom combination for rapid clinical 
diagnosing of depression based on A criteria of DSM-IV and -5, and bereavement is not 
considered a depressive symptom in itself. Of course, future research could investigate whether 
or not our modified definition has any special role in that debate. 
Limitations 
A major strength of the empirical estimates provided in this study is that they are representative 
of the entire US population. In contrast, generalizability to the other populations is a limitation 
and a topic for further study. However, there is evidence for the same underlying structure of 
major depression despite significant cultural differences (Kendler et al., 2015), and depressive 
disorders have been described throughout the written history (Beck, 1967). Likewise, we mainly 
restricted our analysis to lifetime diagnoses and future studies could explore 12-month 
diagnoses, or even immediate reactions to life events. It was established, however, that the 
findings on disability days followed the same qualitative pattern with the same implications for 
diagnostic revisions both for those with lifetime depression diagnosis and for those with episode 
also within the past 12 months (Table 3). In addition, the present study draws from the data 
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collected for prevalence estimation within the old diagnostic system, and the paper is therefore 
limited to the variables that were perceived as relevant for the DSM-IV system. However, clearly 
there was still room for exploration in these data, as we could derive the novel MD definition. 
Although the proposed new diagnostic definition for MD has the undeniable strength of 
excluding MDD cases without observable disability, the new definition may have the drawback of 
increased psychiatric comorbidity. At first sight, this is an obvious outcome of the higher overall 
level of disability in MD cases than in the MDD cases, but the finding persisted despite adjusting 
for the WHODAS disability score. Given these preliminary findings, future studies could 
investigate the novel MD definition in the wider context of the total diagnostic system. 
Although not a limitation regarding the comparison between MD and MDD, the present 
study is generally limited by the fact that full symptom data was available only from individuals 
who had endorsed either anhedonia or sadness criterion, or both. This does not limit analyses in 
the anhedonic population, and our MD is automatically excluded if one does not belong to that 
sub-population. Therefore, diagnostic information was available for the entire sample. However, 
it is possible (even likely) that explorative analyses using wider range of symptoms and other 
etiologic information will eventually achieve even better diagnostic constructs in comparison to 
the present ones. We hope the present analysis encourages such efforts in representative large 
datasets, and also point out that researchers have frequently worked with a larger range of 
symptoms than is available in DSM-5 (Beck, 1967). 
In summary, this study found strong support for re-defining the major depression as "lack 
of interest to all or most things" plus four other symptoms from the set {weight gain, weight loss, 
insomnia, psychomotor retardation, fatigue, feelings of worthlessness, diminished ability to 
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think/concentrate, suicidal ideation/attempt}. This new definition captured all the disability 
implied by DSM-IV Major Depressive Disorder and excluded cases that show no greater disability 
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Table 1. Factor loadings of symptoms in the anhedonic population 
 
 Factor 1 Factor 2 Factor 3 Factor 4 
Weight loss -0.049 0.981 -0.008 0.173 
Weight gain 0.054 -0.608 -0.021 0.132 
Insomnia -0.777 0.093 0.024 0.215 
Hypersomnia 0.994 -0.030 -0.007 0.075 
Psychomotor retardation -0.060 0.035 -0.299 0.362 
Psychomotor agitation -0.057 0.038 0.995 0.016 
Fatigue 0.063 -0.025 -0.113 0.351 
Feelings of worthlessness or guilt 0.010 -0.019 0.033 0.363 
Diminished ability to think or concentrate -0.078 -0.009 0.007 0.441 
Suicidal ideation -0.068 0.019 0.013 0.270 
Note: Varimax-rotated loadings from a 4-factor Exploratory Factor Analysis in the anhedonic 
population (sample n = 3443, estimated population total = 40 818 803). Loadings above 0.10 in 








Table 2. A contingency table for MDD and MD 
 No MD Yes MD Marginal 
No MDD 168 957 187 (81.0%) 5 494 157 (2.6%) 174 451 344 (83.6%) 
Yes MDD 8 831 969 (4.2%) 25 267 305 (12%) 34 099 274 (16.4%) 
Marginal 177 789 156 (85.2%) 30 761 462 (14.8%) 208 550 618 (100%) 
Note: A contingency table of estimated MDD (old definition) and MD (data-driven definition) 
population totals. Respective percentages are given in the parentheses. Notice that the sum of 
marginals is not exactly equal with the estimated population total, 209 500 125 (SE = 10 569 
621) individuals, because of the sampling error in the distinct estimates (sum of domain 
estimates for cell totals vs. direct estimate of population total). The survey-weighted estimates 













Table 3. Quasi-Poisson regression coefficients when predicting number of disability days 
 
    
Model 
    Variable I II III IV V VI VII VIII 
Age 0.01*** 0.01*** 0.01*** 0.01*** 0.01*** 0.01*** 0.01*** 0.01*** 
 
(0.01, 0.01) (0.01, 0.02) (0.01, 0.01) (0.01, 0.01) (0.01, 0.02) (0.01, 0.02) (0.01, 0.01) (0.01, 0.01) 
Male sex -0.12 -0.08 -0.17* -0.16* -0.10 -0.08 -0.16* -0.16* 
 
(-0.29, 0.05) (-0.25, 0.09) (-0.32, -0.01) (-0.32, -0.004) (-0.26, 0.06) (-0.23, 0.08) (-0.32, -0.01) (-0.32, -0.01) 
MDD 0.46*** 
   
0.98*** 
   
 
(0.27, 0.64) 
   
(0.76, 1.20) 









   
(1.05, 1.51) 
  MDD w/o MD 
  
-0.10 
   
0.01 
 
   
(-0.45, 0.25) 
   
(-0.43, 0.45) 
 
MD w/o MDD 
   
1.16*** 
   
1.42*** 
    
(0.90, 1.41) 
   
(1.15, 1.68) 
Constant 0.09 -0.08 0.26* 0.14 -0.0002 -0.13 0.25* 0.15 
 
(-0.17, 0.35) (-0.39, 0.22) (0.04, 0.48) (-0.10, 0.37) (-0.26, 0.26) (-0.39, 0.14) (0.02, 0.48) (-0.08, 0.38) 
Observations 15 565 15 571 15 565 15 571 15 565 15 571 15 565 15 571 
*p<0.05; **p<0.01; ***p<0.001 
Note: Quasi-Poisson regression coefficients when predicting number of disability days per 
month. Four models are shown, depending on one of the independent variables being MDD 
(Major Depressive Disorder; Model I) diagnosis, MD (the newly-suggested Major Depression; 
Model II) diagnosis, MDD without MD (Model III), or MD without MDD (Model IV). The columns 
5‒8 (Models V to VIII) show the same models put for 12-month instead of lifetime diagnoses. The 








Figure 1: Parallel analysis plot in the anhedonic population (Sample n = 3443, corresponding 
estimated population total = 40 818 803). Parallel analysis line shows the expected eigenvalues 
under no correlations, but taking sampling variance into account. Reference line at the value 1 
shows the expectation without any sampling variance. The estimated number of factors is the 
number of descending-order eigenvalues above the parallel-analysis line (i.e., 4). 
 
Figure 2: Disability scores in the diagnostic groups. Forest plot of average WHODAS sub-scale score 
and average episode length in non-depressed individuals [no MD(D)], the Major Depressive Disorder 
sufferers without the new Major Depression diagnosis (MDD w/o MD), the MDD sufferers, the MD 
sufferers, the MD sufferers without MDD (MD w/o MDD). Whiskers denote 95% confidence intervals. 
The episode length is not shown for the "no MD(D)" condition, because these individuals have no 
episodes. 
 
Figure 3: Binary outcomes in the diagnostic groups. Forest plot of odds ratios for DSM-IV disorders 
and other binary outcomes from their regression on the Major Depressive Disorder (MDD) sufferers 
without the new Major Depression (MD) diagnosis (MDD w/o MD), the MDD sufferers, the MD 
sufferers, and the MD sufferers without MDD (MD w/o MDD). Odds ratios for the DSM-IV disorders 
are adjusted for WHODAS disability score to avoid inflated comorbidity due to the previously shown 
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Depressed mood 0.2290 0.979 1.000 
Loss of interest 0.1950 1.000 0.835 
Weight loss 0.1500 0.666 0.650 
Weight gain 0.0318 0.143 0.135 
Insomnia 0.1720 0.757 0.744 
Hypersomnia 0.0349 0.156 0.149 
Psychomotor retardation 0.0883 0.418 0.382 
Psychomotor agitation 0.0239 0.103 0.105 
Fatigue 0.1930 0.877 0.832 
Feelings of worthlessness or guilt 0.0957 0.459 0.417 
Diminished ability to think or concentrate 0.1980 0.890 0.856 
Suicidality 0.1570 0.708 0.678 
Sub-group sample size 20 013 3 443 4 000 
Estimated population total 209 500 125 40 818 803 47 891 758 
Note: Symptom prevalence in the general (1st column), the anhedonic (2nd col), and the sad or low-
mood (3rd col) population. The two last rows show the analytic sample size and the estimate for the 








Supplementary Table S2. Correlations between the depressive symptoms in anhedonic people. 
 
mood wloss wgain insomnia hypersomnia retardation agitation fatigue worthlessness thinking suicidal 
mood 1.000 0.140 -0.290 0.160 -0.220 -0.012 -0.062 -0.053 0.130 0.063 0.170 
wloss 0.140 1.000 -0.920 0.250 -0.220 0.097 0.016 -0.072 -0.053 0.015 0.030 
wgain -0.290 -0.920 1.000 -0.220 0.170 -0.066 -0.120 0.027 0.056 -0.032 -0.068 
insomnia 0.160 0.250 -0.220 1.000 -0.980 0.130 0.085 -0.057 -0.037 0.210 0.150 
hypersomnia -0.220 -0.220 0.170 -0.980 1.000 -0.110 -0.150 0.089 0.024 -0.230 -0.160 
retardation -0.012 0.097 -0.066 0.130 -0.110 1.000 -0.660 0.160 0.100 0.290 -0.037 
agitation -0.062 0.016 -0.120 0.085 -0.150 -0.660 1.000 -0.390 -0.068 -0.210 -0.034 
fatigue -0.053 -0.072 0.027 -0.057 0.089 0.160 -0.390 1.000 0.016 0.130 -0.130 
worthlessness 0.130 -0.053 0.056 -0.037 0.024 0.100 -0.068 0.016 1.000 0.042 0.290 
thinking 0.063 0.015 -0.032 0.210 -0.230 0.290 -0.210 0.130 0.042 1.000 -0.033 
suicidal 0.170 0.030 -0.068 0.150 -0.160 -0.037 -0.034 -0.130 0.290 -0.033 1.000 








Supplementary Table S3. Oblique bi-factor loadings in the anhedonic population 
 
 Factor 1 Factor 2 Factor 3 Factor 4 
Weight loss 0.3590 0.9300 -0.0059 -0.0066 
Weight gain 0.0118 -0.6210 -0.0190 -0.0231 
Insomnia 0.2500 0.0106 0.0163 0.7700 
Hypersomnia 0.0406 0.0047 0.0076 -0.9980 
Psychomotor retardation 0.3670 -0.0296 -0.2960 0.0680 
Psychomotor agitation 0.0119 -0.0011 0.9970 0.0015 
Fatigue 0.3400 -0.0867 -0.1080 -0.0625 
Feelings of worthlessness or guilt 0.3520 -0.0903 0.0382 -0.0175 
Diminished ability to think or concentrate 0.4330 -0.0990 0.0125 0.0701 
Suicidal ideation 0.2700 -0.0376 0.0152 0.0610 
 
Note: Oblique bi-factor analysis in the anhedonic population. The "bifactorQ" function from the 
"GPArotation" R package was applied to the factor loadings and the varimax rotation matrix of the 
main manuscript. This rotation method tries to find a rotation where each symptom loads onto a 
main factor plus one and only one other factor. The results align closely with the varimax-based 
interpretations of the main manuscript, with the exception of factor reordering and that the bi-factor 
model would further excluded weight gain from depressive symptoms. Since exploratory oblique bi-
factor rotation estimates are technically challenging and may involve local maxima, we erred for a 







Supplementary Table S4. Summary of the sample and the diagnostic groups 
 




209 500 125 30 761 462 34 099 274 8 831 969 
Variable N Mean SD Mean SD Mean SD Mean SD 
Age (years) 20013 44.6 17.4 42.2 14.4 42.8 15.1 43.9 16.2 
Male 20013 0.481 0.50 0.365 0.481 0.371 0.483 0.435 0.496 
WHODAS 10871 3.200 8.83 5.98 9.57 4.95 8.45 3.30 6.27 
Disability 
days 
15571 1.88 6.11 3.39 7.89 2.36 7.00 1.72 5.81 
Symptom: 
mood 
20013 0.229 0.420 0.990 0.099 0.990 0.101 0.986 0.117 
Symptom: 
anhedonia 
20013 0.195 0.396 1.000 0.000 0.894 0.308 0.589 0.492 
Symptom: 
weight loss 
20013 0.15 0.357 0.721 0.448 0.68 0.467 0.586 0.493 
Symptom: 
weight gain 
20013 0.032 0.176 0.158 0.365 0.151 0.358 0.112 0.316 
Symptom: 
insomnia 
20013 0.172 0.378 0.833 0.373 0.775 0.418 0.624 0.485 
Symptom: 
hypersomnia 
20013 0.035 0.183 0.133 0.339 0.163 0.369 0.237 0.426 
Symptom: 
mot. retard. 
20013 0.088 0.284 0.498 0.500 0.416 0.493 0.209 0.407 
Symptom: 
mot. agit. 
20013 0.024 0.153 0.105 0.306 0.100 0.301 0.118 0.322 
Symptom: 
fatigue 
20013 0.193 0.395 0.927 0.261 0.887 0.317 0.770 0.421 
Symptom: 
worthlessness 
20013 0.096 0.294 0.546 0.498 0.442 0.497 0.193 0.395 
Symptom: 
thinking 
20013 0.198 0.399 0.960 0.196 0.909 0.288 0.777 0.417 
Symptom: 
suicidal 
20013 0.157 0.363 0.790 0.407 0.712 0.453 0.535 0.499 
Note: Summary of the sample and the diagnostic groups. N refers to the raw number of non-missing 
observations for the indicated variable overall, whereas the Mean and Standard deviation (SD) refer 
to survey-weighted population estimates for that variable in the diagnostic group indicated in the 
sup-headings of the pertinent columns. Abbreviations: "WHODAS" = World Health Organization 
Disability Assessment Schedule -based score; "no MD(D)" = sub-group of those not satisfying MD nor 
MDD criteria; "MD" = sub-group of people satisfying the (new) Major Depression criteria; "MDD" = 
sub-group satisfying the (old) Major Depressive Disorder criteria; "MDD w/o MD" = sub-group of 
people satisfying the (old) MDD criteria without satisfying the (new) MD criteria. "All" refers to the 
entire sample/US population. 
